I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Treatment effectiveness of alemtuzumab compared with natali..:
Kalincik, T
;
Brown, JWL
;
Robertson, N
...
https://www.repository.cam.ac.uk/handle/1810/263284. , 2017
Link:
https://www.repository.cam.ac.uk/handle/1810/263284
RT Journal T1
Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study
UL https://suche.suub.uni-bremen.de/peid=base-ftunivcam:oai:www.repository.cam.ac.uk:1810_263284&Exemplar=1&LAN=DE A1 Kalincik, T A1 Brown, JWL A1 Robertson, N A1 Willis, M A1 Scolding, N A1 Rice, CM A1 Wilkins, A A1 Pearson, O A1 Ziemssen, T A1 Hutchinson, M A1 McGuigan, C A1 Jokubaitis, V A1 Spelman, T A1 Horakova, D A1 Havrdova, E A1 Trojano, M A1 Izquierdo, G A1 Lugaresi, A A1 Prat, A A1 Girard, M A1 Duquette, P A1 Grammond, P A1 Alroughani, R A1 Pucci, E A1 Sola, P A1 Hupperts, R A1 Lechner-Scott, J A1 Terzi, M A1 Van Pesch, V A1 Rozsa, C A1 Grand'Maison, F A1 Boz, C A1 Granella, F A1 Slee, M A1 Spitaleri, D A1 Olascoaga, J A1 Bergamaschi, R A1 Verheul, F A1 Vucic, S A1 McCombe, P A1 Hodgkinson, S A1 Sanchez-Menoyo, JL A1 Ampapa, R A1 Simo, M A1 Csepany, T A1 Ramo, C A1 Cristiano, E A1 Barnett, M A1 Butzkueven, H A1 Coles, A A1 MSBase Study Group PB Elsevier; http://dx.doi.org/10.1016/s1474-4422(17)30007-8; The Lancet Neurology YR 2017 K1 Adult K1 Alemtuzumab K1 Antibodies K1 Monoclonal K1 Humanized K1 Cohort Studies K1 Databases K1 Bibliographic K1 Disability Evaluation K1 Female K1 Fingolimod Hydrochloride K1 Humans K1 Immunologic Factors K1 Interferon-beta K1 Male K1 Multiple Sclerosis K1 Relapsing-Remitting K1 Natalizumab K1 Treatment Outcome K1 Young Adult JF https://www.repository.cam.ac.uk/handle/1810/263284 LK http://dx.doi.org/https://www.repository.cam.ac.uk/handle/1810/263284 DO https://www.repository.cam.ac.uk/handle/1810/263284 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)